December 19, 2025 In follow-up to the Executive Order issued in May, the Centers for Medicare & Medicaid Services (CMS) today issued two proposed rules that would implement Most Favored […]
The EACH/PIC Coalition submitted comments to the Oregon PDAB, in advance of their December meeting, providing input on the cost review process. The letter highlighted the challenging conditions the board
The EACH/PIC Coalition submitted comments to the Colorado PDAAC on their proposed recommendations for engaging patients in the cost review process. The letter urges for the implementation of reforms that
December 3, 2025 On November 25, 2025, the Centers for Medicare & Medicaid Services (CMS) announced the Maximum Fair Prices (MFPs) for 15 drugs in the second negotiation cycle of
The EACH/PIC Coalition submitted a comment letter to the Maryland PDAB providing input on the draft annual report to the Maryland legislature. The letter stated: “We urge the board to
The EACH/PIC Coalition sent a letter to Members of Congress drawing attention to the limitations and potential harm of price-setting policies. The letter instead urged Congress to advance reforms that
The EACH/PIC Coalition submitted comment letters to the Maryland PDAB, providing input and feedback on the drug reviews for Ozempic and Trulicity and the proposed UPL framework for Jardiance and
Following the decision of the Colorado PDAB to implement an upper payment limit (UPL) for the drug Enbrel, the EACH/PIC Coalition sent a letter to members of the Colorado Legislature
The EACH/PIC Coalition submitted comments to the Oregon PDAB in advance of their October meeting on policies proposed for the annual report to the Oregon legislature. The letter followed up
By Sara Wilson Democratic leaders, health care providers and consumer advocates praised a Colorado board’s decision last week to cap the price of a prescription drug used to treat rheumatoid
